Biotech Investors & VC Firms

2475 firms in this list, with a median first check of $500K. 505 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
PL Planet 9 Capital JOKHKO3 people	88🔒	Bergen	NO	Seed	—	+ Add to CRM
K3 K3 Ventures MXSLCTCC20 people	88🔒	Singapore	SG	Seed–Growth	—	+ Add to CRM
RI Ridgeback Capital WHWH2 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
AL Alta Partners GNFCLRRM10 people	88🔒	Jackson	US	Seed–Series A	$1M – $12M	+ Add to CRM
UN University System of Maryland Momentum Fund MRDCEHGC19 people	88🔒	Baltimore	US	Seed–Series A	$150K – $500K	+ Add to CRM
GE Georgian JBJLSCEW18 people · Leads rounds	88🔒	Toronto, Ontario	CA	Series C–Growth	$25M – $100M	+ Add to CRM
MA Material Impact ASCRBSCT18 people · Follows rounds	88🔒	Boston	US	Seed–Series A	$100K – $10M	+ Add to CRM
PA Pangaea Ventures Us Inc. CEAHJGSA15 people · Follows rounds	88🔒	Vancouver	CA	Seed–Series B	$500K – $1.5M	+ Add to CRM
RE Red Tree Venture GYHLJCJC27 people · Leads rounds	88🔒	San Diego	US	Seed–Series B	—	+ Add to CRM
DE Decacorn Capital AFDMAA17 people	88🔒	Singapore	SG	Seed–Series B	$300K – $600K	+ Add to CRM
DE Deep Science Ventures DMAA20 people	88🔒	London	GB	Pre-Seed–Seed	—	+ Add to CRM
UT Utah Innovation Fund ASDPEBGW29 people	88🔒	Salt Lake City	US	Pre-Seed–Seed	—	+ Add to CRM
IT IT-Farm Corporation JN吉広向隆春伸7 people	88🔒	Tokyo	JP	Seed–Series A	—	+ Add to CRM
PA Panacea Venture JHAAANAC22 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
BP BPOC GMAHGPMT23 people	88🔒	Chicago	US	Growth	$25M – $100M	+ Add to CRM
CO Conduit Connect EDGMBOAR26 people	88🔒	London	GB	Pre-Seed–Series A	—	+ Add to CRM
BE Beyond Ventures LMMHWCAC16 people · Follows rounds	88🔒	Hong Kong	HK	Seed–Series B	$100K – $5M	+ Add to CRM
FO Four Cities LBBHMMAS4 people	88🔒	Newton	US	Seed–Series A	—	+ Add to CRM
K2 K2 HealthVentures PSAAASDK22 people	88🔒	Boston	US	Growth–Late Stage	—	+ Add to CRM
SI Signet Healthcare Partners JGAFJENP13 people · Leads rounds	88🔒	New York	US	Growth	$10M – $50M	+ Add to CRM
AN Angel Bridge Co.,Ltd. YKRYTKAT9 people	88🔒	Tokyo	JP	Seed–Series B	$70K – $33M	+ Add to CRM
DE Dentsu Ventures DTKHHNTN12 people	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
CA Catalyst Investments, L.P. ECJCSFYS29 people · Leads rounds	88🔒	Tel Aviv	IL	Growth–Late Stage	$1.5M – $5M	+ Add to CRM
SE Series Ventures LKAKENGW26 people	88🔒	Changwon	KR	Seed–Series A	—	+ Add to CRM

Planet 9 Capital

BergenSeed

JOKHKO3 people

K3 Ventures

SingaporeSeed–Growth

MXSLCTCC20 people

Ridgeback Capital

New YorkSeed–Late Stage

WHWH2 people

Alta Partners

JacksonSeed–Series A$1M – $12M

GNFCLRRM10 people

University System of Maryland Momentum Fund

BaltimoreSeed–Series A$150K – $500K

MRDCEHGC19 people

Georgian

Toronto, OntarioSeries C–Growth$25M – $100M

JBJLSCEW18 people

Material Impact

BostonSeed–Series A$100K – $10M

ASCRBSCT18 people

Pangaea Ventures Us Inc.

VancouverSeed–Series B$500K – $1.5M

CEAHJGSA15 people

Red Tree Venture

San DiegoSeed–Series B

GYHLJCJC27 people

Decacorn Capital

SingaporeSeed–Series B$300K – $600K

AFDMAA17 people

Deep Science Ventures

LondonPre-Seed–Seed

DMAA20 people

Utah Innovation Fund

Salt Lake CityPre-Seed–Seed

ASDPEBGW29 people

IT-Farm Corporation

TokyoSeed–Series A

JN吉広向隆春伸7 people

Panacea Venture

SingaporeSeed–Late Stage

JHAAANAC22 people

BPOC

ChicagoGrowth$25M – $100M

GMAHGPMT23 people

Conduit Connect

LondonPre-Seed–Series A

EDGMBOAR26 people

Beyond Ventures

Hong KongSeed–Series B$100K – $5M

LMMHWCAC16 people

Four Cities

NewtonSeed–Series A

LBBHMMAS4 people

K2 HealthVentures

BostonGrowth–Late Stage

PSAAASDK22 people

Signet Healthcare Partners

New YorkGrowth$10M – $50M

JGAFJENP13 people

Angel Bridge Co.,Ltd.

TokyoSeed–Series B$70K – $33M

YKRYTKAT9 people

Dentsu Ventures

TokyoSeed–Late Stage

DTKHHNTN12 people

Catalyst Investments, L.P.

Tel AvivGrowth–Late Stage$1.5M – $5M

ECJCSFYS29 people

Series Ventures

ChangwonSeed–Series A

LKAKENGW26 people

Data sourced from public filings and firms' own websites — see our methodology.